Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14618)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 18, 2017 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cholankeril G, Patel R, Khurana S, Satapathy SK. Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management. World J Hepatol 2017; 9(11): 533-543 [PMID: 28469809 DOI: 10.4254/wjh.v9.i11.533] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i11/533.htm |
| Number | Citing Articles |
| 1 |
Gehad A. Abdel Jaleel, Sally A. Al-Awdan, Rania F. Ahmed, Omar A.H. Ahmed-Farid, Dalia O. Saleh. Melatonin regulates neurodegenerative complications associated with NAFLD via enhanced neurotransmission and cellular integrity: a correlational study. Metabolic Brain Disease 2020; 35(8): 1251 doi: 10.1007/s11011-020-00593-4
|
| 2 |
Yoshio Shimizu, Takafumi Tamura, Akira Kemmochi, Yohei Owada, Yusuke Ozawa, Katsuji Hisakura, Takashi Matsuzaka, Hitoshi Shimano, Noriyuki Nakano, Shingo Sakashita, Tatsuya Oda, Nobuhiro Ohkohchi. Oxidative stress and Liver X Receptor agonist induce hepatocellular carcinoma in Non‐alcoholic steatohepatitis model. Journal of Gastroenterology and Hepatology 2021; 36(3): 800 doi: 10.1111/jgh.15239
|
| 3 |
Rashmi Pathak, Avinash Kumar. Post-Transcriptional Gene Regulation in Human Disease. 2022; : 255 doi: 10.1016/B978-0-323-91305-8.00003-X
|
| 4 |
Tyler L. Bissoondial, Anthony J. Pellicano, Itzhak D. Goldberg, Prakash Narayan. Identification of disease-associated microRNA in a diet-induced model of nonalcoholic steatohepatitis. Molecular Omics 2021; 17(6): 911 doi: 10.1039/D1MO00274K
|
| 5 |
Pratima Dibba, Andrew Li, George Cholankeril, Umair Iqbal, Chiranjeevi Gadiparthi, Muhammad Ali Khan, Donghee Kim, Aijaz Ahmed. Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease. Medicines 2018; 5(2): 47 doi: 10.3390/medicines5020047
|
| 6 |
Naga Swetha Samji, Rajanshu Verma, Krishna Chaitanya Keri, Ashwani K. Singal, Aijaz Ahmed, Mary Rinella, David Bernstein, Manal F. Abdelmalek, Sanjaya K. Satapathy. Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges. Digestive Diseases and Sciences 2019; 64(12): 3413 doi: 10.1007/s10620-019-05716-1
|
| 7 |
Eman A. Ahmed, Marwa O. El-Derany, Ali Mostafa Anwar, Essa M. Saied, Sameh Magdeldin. Metabolomics and Lipidomics Screening Reveal Reprogrammed Signaling Pathways toward Cancer Development in Non-Alcoholic Steatohepatitis. International Journal of Molecular Sciences 2022; 24(1): 210 doi: 10.3390/ijms24010210
|
| 8 |
Tyler L. Bissoondial, Yiguang Han, Stephanie Mullan, Amrit K. Pabla, Kiera Spahn, Steven Shi, Lana Zheng, Ping Zhou, Kai Jiang, Natalia Prakash, Shraddha Bhutkar, Quaisar Ali, Jingsong Li, Zhijian Hu, Anthony J. Pellicano, Itzhak D. Goldberg, Prakash Narayan. Liver Biopsy Hydroxyproline Content Is a Diagnostic for Hepatocellular Carcinoma in Murine Models of Nonalcoholic Steatohepatitis. Diagnostics 2020; 10(10): 784 doi: 10.3390/diagnostics10100784
|
| 9 |
Anthony Pellicano, Stephanie Mullan, Itzhak Goldberg, Prakash Narayan. Hepatic mRNA Expression Levels of the Oncogenes Alpha-Fetoprotein and Osteopontin as Diagnostics for Liver Cancer in a Murine Model of Diet-Induced Non-Alcoholic Steatohepatitis. Processes 2021; 9(9): 1516 doi: 10.3390/pr9091516
|
| 10 |
Catherine T. Frenette, Ari J. Isaacson, Irene Bargellini, Sammy Saab, Amit G. Singal. A Practical Guideline for Hepatocellular Carcinoma Screening in Patients at Risk. Mayo Clinic Proceedings: Innovations, Quality & Outcomes 2019; 3(3): 302 doi: 10.1016/j.mayocpiqo.2019.04.005
|
| 11 |
Simon Haefliger, Dina Milowich, Amedeo Sciarra, Mounir Trimeche, Justine Bouilly, Julie Kaiser, Stephanie Volpi, Jean-Philippe Brouland, Christine Sempoux, Laurence de Leval. Primary hepatic marginal B cell lymphoma of mucosa-associated lymphoid tissue (MALT) and non-alcoholic steatohepatitis (NASH): more than a coincidence?. Annals of Hematology 2019; 98(6): 1513 doi: 10.1007/s00277-018-3565-5
|
| 12 |
Daniela Gabbia, Luana Cannella, Sara De Martin. The Role of Oxidative Stress in NAFLD–NASH–HCC Transition—Focus on NADPH Oxidases. Biomedicines 2021; 9(6): 687 doi: 10.3390/biomedicines9060687
|
| 13 |
Jorge Gutiérrez-Cuevas, Silvia Lucano-Landeros, Daniel López-Cifuentes, Arturo Santos, Juan Armendariz-Borunda. Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies. Cancers 2022; 15(1): 23 doi: 10.3390/cancers15010023
|
| 14 |
Scott L. Friedman, Arun J. Sanyal. The future of hepatology. Hepatology 2023; doi: 10.1097/HEP.0000000000000389
|
| 15 |
Takaaki Izumi, Takuya Sho, Kenichi Morikawa, Taku Shigesawa, Kazuharu Suzuki, Akihisa Nakamura, Masatsugu Ohara, Naoki Kawagishi, Machiko Umemura, Tomoe Shimazaki, Megumi Kimura, Masato Nakai, Goki Suda, Mitsuteru Natsuizaka, Koji Ogawa, Yusuke Kudo, Mutsumi Nishida, Kota Ono, Masaru Baba, Ken Furuya, Naoya Sakamoto. Assessing the risk of hepatocellular carcinoma by combining liver stiffness and the controlled attenuation parameter. Hepatology Research 2019; 49(10): 1207 doi: 10.1111/hepr.13391
|
| 16 |
Maria Teresa Guagnano, Damiano D'Ardes, Rossi Ilaria, Francesca Santilli, Cosima Schiavone, Marco Bucci, Francesco Cipollone. Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome in Women: Effects of Lifestyle Modifications. Journal of Clinical Medicine 2022; 11(10): 2759 doi: 10.3390/jcm11102759
|
| 17 |
Karthik Balakrishnan. Hepatocellular carcinoma stage: an almost loss of fatty acid metabolism and gain of glucose metabolic pathways dysregulation. Medical Oncology 2022; 39(12) doi: 10.1007/s12032-022-01839-0
|
| 18 |
Reem El-Shenawy, Sally Farouk, Naiera Helmy, Noha Bader El Din. Hepatitis C - Recent Advances. 2023; doi: 10.5772/intechopen.1001057
|
| 19 |
Tianpeng Zhang, Junjie Hu, Xiaomei Wang, Xiaoling Zhao, Zhuoyu Li, Junqi Niu, Clifford J. Steer, Guohua Zheng, Guisheng Song. MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-κB-TNFα pathway. Journal of Hepatology 2019; 70(1): 87 doi: 10.1016/j.jhep.2018.08.026
|
| 20 |
|
| 21 |
Mélissa Léveillé, Jennifer L. Estall. Mitochondrial Dysfunction in the Transition from NASH to HCC. Metabolites 2019; 9(10): 233 doi: 10.3390/metabo9100233
|
| 22 |
LiKang Chin, Neil D. Theise, Abigail E. Loneker, Paul A. Janmey, Rebecca G. Wells. Lipid droplets disrupt mechanosensing in human hepatocytes. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 319(1): G11 doi: 10.1152/ajpgi.00098.2020
|
| 23 |
Jelena Krstic, Markus Galhuber, Tim J. Schulz, Michael Schupp, Andreas Prokesch. p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine. International Journal of Molecular Sciences 2018; 19(3): 921 doi: 10.3390/ijms19030921
|
| 24 |
Ahmed Ayyash, Alison C. Holloway. Fluoxetine‐induced hepatic lipid accumulation is mediated by prostaglandin endoperoxide synthase 1 and is linked to elevated 15‐deoxy‐Δ12,14PGJ2. Journal of Applied Toxicology 2022; 42(6): 1004 doi: 10.1002/jat.4272
|
| 25 |
Edda Russo, Camila Fiorindi, Francesco Giudici, Amedeo Amedei. Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma. World Journal of Hepatology 2022; 14(2): 372-385 doi: 10.4254/wjh.v14.i2.372
|
| 26 |
Utibe-Abasi Udoh, Juan D Sanabria, Pradeep K Rajan, Moumita Banerjee, Mathew Schade, Jacqueline A Sanabria, Gary Smith, Gideon Udoh, Komal Sodhi, Sandrine Pierre, Joseph I Shapiro, Juan R Sanabria. Liver Cancer. 2021; : 55 doi: 10.36255/exonpublications.livercancer.2021.ch3
|
| 27 |
Konstantinos Arvanitakis, Theocharis Koufakis, Kalliopi Kotsa, Georgios Germanidis. The effects of sodium-glucose cotransporter 2 inhibitors on hepatocellular carcinoma: From molecular mechanisms to potential clinical implications. Pharmacological Research 2022; 181: 106261 doi: 10.1016/j.phrs.2022.106261
|
| 28 |
Edison Roberto PARISE. NONALCOHOLIC FATTY LIVER DISEASE (NAFLD), MORE THAN A LIVER DISEASE. Arquivos de Gastroenterologia 2019; 56(3): 243 doi: 10.1590/s0004-2803.201900000-45
|
| 29 |
Emma Henriksson, Birgitte Andersen. FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.601349
|
| 30 |
Shuo Yuan, Hua-Min Zhang, Jia-Xin Li, You Li, Qi Wang, Guang-Yao Kong, Ao-Han Li, Ji-Xing Nan, Ying-Qing Chen, Qing-Gao Zhang. Gasotransmitters in non-alcoholic fatty liver disease: just the tip of the iceberg. European Journal of Pharmacology 2023; 954: 175834 doi: 10.1016/j.ejphar.2023.175834
|
| 31 |
Paul Kubes, Craig Jenne. Immune Responses in the Liver. Annual Review of Immunology 2018; 36(1): 247 doi: 10.1146/annurev-immunol-051116-052415
|
| 32 |
Youxi Yu, Xiaoju Shi, Xingtong Wang, Ping Zhang, Ou Bai, Yan Li. Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases. Cell & Bioscience 2022; 12(1) doi: 10.1186/s13578-022-00763-0
|
| 33 |
Michael Kram. Galectin-3 inhibition as a potential therapeutic target in non-alcoholic steatohepatitis liver fibrosis. World Journal of Hepatology 2023; 15(2): 201-207 doi: 10.4254/wjh.v15.i2.201
|
| 34 |
Molood Bagherieh, Asma Kheirollahi, Fahimeh Zamani-Garmsiri, Solaleh Emamgholipour, Reza Meshkani. Folic acid ameliorates palmitate-induced inflammation through decreasing homocysteine and inhibiting NF-κB pathway in HepG2 cells. Archives of Physiology and Biochemistry 2023; 129(4): 893 doi: 10.1080/13813455.2021.1878539
|
| 35 |
Lionel Fizanne, Alexandre Villard, Nadia Benabbou, Sylvain Recoquillon, Raffaella Soleti, Erwan Delage, Mireille Wertheimer, Xavier Vidal‐Gómez, Thibauld Oullier, Samuel Chaffron, M. Carmen Martínez, Michel Neunlist, Jérôme Boursier, Ramaroson Andriantsitohaina. Faeces‐derived extracellular vesicles participate in the onset of barrier dysfunction leading to liver diseases. Journal of Extracellular Vesicles 2023; 12(2) doi: 10.1002/jev2.12303
|
| 36 |
Mayank Jain, Jayanthi Venkataraman, Joy Varghese, Mukul Vij, Mettu S Reddy, Mohamed Rela. Explant liver evaluation decodes the mystery of cryptogenic cirrhosis!. JGH Open 2020; 4(1): 39 doi: 10.1002/jgh3.12200
|
| 37 |
Mohamed A. Nasr, Radwa Ayman Salah, M. Abd Elkodous, Shimaa E. Elshenawy, Nagwa El-Badri. Dysregulated MicroRNA Fingerprints and Methylation Patterns in Hepatocellular Carcinoma, Cancer Stem Cells, and Mesenchymal Stem Cells. Frontiers in Cell and Developmental Biology 2019; 7 doi: 10.3389/fcell.2019.00229
|
| 38 |
Ryo Yamauchi, Hidetoshi Takedatsu, Keiji Yokoyama, Eri Yamauchi, Motoko Kawashima, Takahiro Nagata, Yotaro Uchida, Takanori Kitaguchi, Tomotaka Higashi, Hiromi Fukuda, Naoaki Tsuchiya, Kazuhide Takata, Takashi Tanaka, Daisuke Morihara, Yasuaki Takeyama, Satoshi Shakado, Shotaro Sakisaka, Fumihito Hirai. Elobixibat, an ileal bile acid transporter inhibitor, ameliorates non-alcoholic steatohepatitis in mice. Hepatology International 2021; 15(2): 392 doi: 10.1007/s12072-020-10107-0
|
| 39 |
Alexandre Villard, Jérôme Boursier, Ramaroson Andriantsitohaina. Bacterial and eukaryotic extracellular vesicles and nonalcoholic fatty liver disease: new players in the gut-liver axis?. American Journal of Physiology-Gastrointestinal and Liver Physiology 2021; 320(4): G485 doi: 10.1152/ajpgi.00362.2020
|
| 40 |
Priyankar Dey, Joshua B. Kim, Chureeporn Chitchumroonchokchai, Jinhui Li, Geoffrey Y. Sasaki, Bryan D. Olmstead, Katie L. Stock, Jennifer M. Thomas-Ahner, Steven K. Clinton, Richard S. Bruno. Green tea extract inhibits early oncogenic responses in mice with nonalcoholic steatohepatitis. Food & Function 2019; 10(10): 6351 doi: 10.1039/C9FO01199D
|
| 41 |
I. Glory Josephine, K. Punnagai. In Vitro Cytotoxicity Activity of Ethanolic Leaf Extract of Costus Igneus Against Hepatocellular Carcinoma (HepG2) Cells. Biomedical and Pharmacology Journal 2019; 12(2): 901 doi: 10.13005/bpj/1715
|
| 42 |
Utibe-Abasi S. Udoh, Moumita Banerjee, Pradeep K. Rajan, Juan D. Sanabria, Gary Smith, Mathew Schade, Jacqueline A. Sanabria, Yuto Nakafuku, Komal Sodhi, Sandrine V. Pierre, Joseph I. Shapiro, Juan R. Sanabria. Tumor-Suppressor Role of the α1-Na/K-ATPase Signalosome in NASH Related Hepatocellular Carcinoma. International Journal of Molecular Sciences 2022; 23(13): 7359 doi: 10.3390/ijms23137359
|
| 43 |
Zun Siong Low, Damien Chua, Hong Sheng Cheng, Rachel Tee, Wei Ren Tan, Christopher Ball, Norliza Binte Esmail Sahib, Ser Sue Ng, Jing Qu, Yingzi Liu, Haiyu Hong, Chaonong Cai, Nandini Chilagondanahalli Lakshmi Rao, Aileen Wee, Mark Dhinesh Muthiah, Zoë Bichler, Barbara Mickelson, Mei Suen Kong, Vanessa Shiyun Tay, Zhuang Yan, Jiapeng Chen, Aik Seng Ng, Yun Sheng Yip, Marcus Ivan Gerard Vos, Nicole Ashley Tan, Dao Liang Lim, Debbie Xiu En Lim, Manesh Chittezhath, Jadegoud Yaligar, Sanjay Kumar Verma, Harish Poptani, Xue Li Guan, Sambasivam Sendhil Velan, Yusuf Ali, Liang Li, Nguan Soon Tan, Walter Wahli. The LIDPAD Mouse Model Captures the Multisystem Interactions and Extrahepatic Complications in MASLD. Advanced Science 2024; doi: 10.1002/advs.202404326
|
| 44 |
S. M. Touhidul Islam, Arun P. Palanisamy, Gabriel R. Chedister, Michael G. Schmidt, David N. B. Lewin, Kenneth D. Chavin, Wan-Long Chuang. Unsaturated or saturated dietary fat-mediated steatosis impairs hepatic regeneration following partial hepatectomy in mice. PLOS ONE 2023; 18(5): e0284428 doi: 10.1371/journal.pone.0284428
|
| 45 |
T. I. Ahmed, E. Mamdouh, N. R. Ismael, O. O. Abdelaleem, N. F. Hemeda, M. A. Hegazy, R. A. Ali. MiR-378a-3p and miR-181b-5p as nonalcoholic steatohepatitis non-invasive diagnostic biomarkers and their correlations with liver fibrosis. The Ukrainian Biochemical Journal 2024; 96(4): 69 doi: 10.15407/ubj96.04.069
|
| 46 |
Kathleen R. Smith, Wenshan Wang, Melissa R. Miller, Magalie Boucher, Jessica E. Reynold, Natalie A. Daurio, Dongmei Li, Dinesh Hirenallur-Shanthappa, Youngwook Ahn, David A. Beebe, Kenneth L. Kelly, Trenton T. Ross, Kendra K. Bence, Min Wan. GPAT1 Deficiency in Mice Modulates NASH Progression in a Model-Dependent Manner. Cellular and Molecular Gastroenterology and Hepatology 2023; doi: 10.1016/j.jcmgh.2023.10.002
|
| 47 |
Madalina-Gabriela Taru, Monica Lupsor-Platon. Exploring Opportunities to Enhance the Screening and Surveillance of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease (NAFLD) through Risk Stratification Algorithms Incorporating Ultrasound Elastography. Cancers 2023; 15(16): 4097 doi: 10.3390/cancers15164097
|
| 48 |
Bianca M. Arendt, Anastasia Teterina, Paulina Pettinelli, Elena M. Comelli, David W.L. Ma, Scott K. Fung, Ian D. McGilvray, Sandra E. Fischer, Johane P. Allard. Cancer-related gene expression is associated with disease severity and modifiable lifestyle factors in non-alcoholic fatty liver disease. Nutrition 2019; 62: 100 doi: 10.1016/j.nut.2018.12.001
|
| 49 |
A. T. Billeter, B. P. Müller-Stich. Metabolische Chirurgie. Der Chirurg 2019; 90(2): 157 doi: 10.1007/s00104-018-0786-z
|
| 50 |
V. V. Breder, I. A. Pokataev, V. V. Petkau, M. Yu. Fedyanin, E. V. Ledin, V. E. Zagainov, S. V. Shapoval, D. A. Granov, P. V. Balakhnin, N. E. Kudashkin, I. V. Pogrebnyakov, N. V. Popova, E. A. Moroz. Advisory board resolution: The role of the adjuvant atezolizumab plus bevacizumab in patients with hepatocellular carcinoma at high risk of recurrence following surgical resection or ablation. Meditsinskiy sovet = Medical Council 2024; (22): 20 doi: 10.21518/ms2023-450
|
| 51 |
Zulqar Islam, Brett Hausauer, Jayanth Keshavamurthy, Darko Pucar. Rapidly Lethal Ruptured Hepatocellular Carcinoma With Disseminated Peritoneal Carcinomatosis on FDG PET/CT. Clinical Nuclear Medicine 2019; 44(11): e622 doi: 10.1097/RLU.0000000000002650
|
| 52 |
Jesús Rivera-Esteban, Sergio Muñoz-Martínez, Mónica Higuera, Elena Sena, María Bermúdez-Ramos, Juan Bañares, María Martínez-Gomez, M. Serra Cusidó, Alba Jiménez-Masip, Sven M. Francque, Frank Tacke, Beatriz Minguez, Juan M. Pericàs. Phenotypes of Metabolic Dysfunction–Associated Steatotic Liver Disease–Associated Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology 2024; 22(9): 1774 doi: 10.1016/j.cgh.2024.03.028
|
| 53 |
Anne Hwang, Christopher Shi, Edward Zhu, Farha Naaz, Ping Zhou, Zainab Rasheed, Michelle Liu, Lindsey S. Jung, Bin Duan, Jingsong Li, Kai Jiang, Latha Paka, Satishkumar V. Gadhiya, Dibyendu Dana, Quaisar Ali, Michael A. Yamin, Itzhak D. Goldberg, Prakash Narayan, Mahesh Narayan. Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASH. PLOS ONE 2018; 13(6): e0198937 doi: 10.1371/journal.pone.0198937
|
| 54 |
Monica Lupsor-Platon, Teodora Serban, Alexandra-Iulia Silion, Alexandru Tirpe, Mira Florea. Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Step Forward for Better Evaluation Using Ultrasound Elastography. Cancers 2020; 12(10): 2778 doi: 10.3390/cancers12102778
|
| 55 |
|
| 56 |
Lydie Carreres, Zuzana Macek Jílková, Guillaume Vial, Patrice N. Marche, Thomas Decaens, Hervé Lerat. Modeling Diet-Induced NAFLD and NASH in Rats: A Comprehensive Review. Biomedicines 2021; 9(4): 378 doi: 10.3390/biomedicines9040378
|
| 57 |
Marina Cecilia Vera, María Eugenia Biancardi, Hebe Bottai, María Cristina Lugano, Ariel Darío Quiroga, Gerardo Bruno Pisani, Alejandra Beatriz Quintana. First approaches for the transplantation of hepatocytes from Wistar rat preneoplastic livers into healthy recipients. Revista Española de Enfermedades Digestivas 2019; doi: 10.17235/reed.2019.5830/2018
|
| 58 |
Hang Yin, Anhua Shi, Junzi Wu. Platelet-Activating Factor Promotes the Development of Non-Alcoholic Fatty Liver Disease. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022; : 2003 doi: 10.2147/DMSO.S367483
|
| 59 |
Marius Farcas, Andrei-Alexandru Gavrea, Diana Gulei, Calin Ionescu, Alexandru Irimie, Cristina S. Catana, Ioana Berindan-Neagoe. SIRT1 in the Development and Treatment of Hepatocellular Carcinoma. Frontiers in Nutrition 2019; 6 doi: 10.3389/fnut.2019.00148
|
| 60 |
Madunil A. Niriella, Uditha Dassanayake, Hithanadura J. de Silva. ‘Mistakes in managing non-alcoholic fatty liver disease and how to avoid them’. Scandinavian Journal of Gastroenterology 2023; 58(3): 223 doi: 10.1080/00365521.2022.2123252
|
| 61 |
Zobair M. Younossi, Radhika P. Tampi, Fatema Nader, Issah M. Younossi, Rebecca Cable, Manirath Srishord, Andrei Racila. Hypothetical treatment of patients with non‐alcoholic steatohepatitis: Potential impact on important clinical outcomes. Liver International 2020; 40(2): 308 doi: 10.1111/liv.14292
|
| 62 |
Ayana R. Kumar, Bhagyalakshmi Nair, Adithya Jayaprakash Kamath, Lekshmi R. Nath, Daniela Calina, Javad Sharifi-Rad. Impact of gut microbiota on metabolic dysfunction-associated steatohepatitis and hepatocellular carcinoma: pathways, diagnostic opportunities and therapeutic advances. European Journal of Medical Research 2024; 29(1) doi: 10.1186/s40001-024-02072-3
|
| 63 |
H. Taflin, L. Hafström, E. Holmberg, M. Castedal, P. Lindnér. The impact of increased immigration to Sweden on the incidence and treatment of patients with HCC and underlying liver disease. Scandinavian Journal of Gastroenterology 2019; 54(6): 746 doi: 10.1080/00365521.2019.1627580
|
| 64 |
Salem Alsaqal, Paul Hockings, Håkan Ahlström, Anders Gummesson, Anders Hedström, Johannes Hulthe, Lars Johansson, Heiko G. Niessen, Corinna Schoelch, Christian Schultheis, Johan Vessby, Alkwin Wanders, Fredrik Rorsman, Charlotte Ebeling Barbier. The Combination of MR Elastography and Proton Density Fat Fraction Improves Diagnosis of Nonalcoholic Steatohepatitis. Journal of Magnetic Resonance Imaging 2022; 56(2): 368 doi: 10.1002/jmri.28040
|
| 65 |
Yedidya Saiman, Andres Duarte-Rojo, Mary E. Rinella. Fatty Liver Disease: Diagnosis and Stratification. Annual Review of Medicine 2022; 73(1): 529 doi: 10.1146/annurev-med-042220-020407
|
| 66 |
Andra-Iulia Suceveanu, Laura Mazilu, Andreea-Daniela Gheorghe, Anca Pantea Stoian, Felix Voinea, Adrian-Paul Suceveanu. Liver Cancer. 2018; doi: 10.5772/intechopen.80527
|
| 67 |
Ozlem Kucukoglu, Jan-Peter Sowa, Guillermo Daniel Mazzolini, Wing-Kin Syn, Ali Canbay. Hepatokines and adipokines in NASH-related hepatocellular carcinoma. Journal of Hepatology 2021; 74(2): 442 doi: 10.1016/j.jhep.2020.10.030
|
| 68 |
Gabriel Scarlat, Bassil Dona, Mihai Cârstea, Marilena Stoian. Insights into Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. Internal Medicine 2022; 19(1): 61 doi: 10.2478/inmed-2022-0198
|
| 69 |
Melissa Yepmo, Jean-Baptiste Potier, Michel Pinget, Anastasia Grabarz, Karim Bouzakri, Aurore Dumond Bourie. Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complications. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1035159
|
| 70 |
Talhah Zubair, Timothy Yen, Gordon Gao. Solitary Extrahepatic Intramuscular Metastasis from Cryptogenic Hepatocellular Carcinoma. ACG Case Reports Journal 2018; 5(1): e64 doi: 10.14309/crj.2018.64
|
| 71 |
Atsushi Oyama, Kazuhiro Nouso, Kenichi Yoshimura, Yuki Morimoto, Shinichiro Nakamura, Hideki Onishi, Akinobu Takaki, Shouta Iwadou, Kazuya Kariyama, Kenji Kuwaki, Kazuhisa Yabushita, Kosaku Sakaguchi, Jyunichi Toshimori, Haruhiko Kobashi, Akio Moriya, Masaharu Ando, Hiroyuki Okada. Randomized controlled study to examine the efficacy of hepatic arterial infusion chemotherapy with cisplatin before radiofrequency ablation for hepatocellular carcinoma. Hepatology Research 2021; 51(6): 694 doi: 10.1111/hepr.13633
|
| 72 |
Ivana Milosevic, Ankica Vujovic, Aleksandra Barac, Marina Djelic, Milos Korac, Aleksandra Radovanovic Spurnic, Ivana Gmizic, Olja Stevanovic, Vladimir Djordjevic, Nebojsa Lekic, Edda Russo, Amedeo Amedei. Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature. International Journal of Molecular Sciences 2019; 20(2): 395 doi: 10.3390/ijms20020395
|
| 73 |
George Cholankeril, Hashem B. El-Serag. Current Challenges and Future Direction in Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. Seminars in Liver Disease 2023; 43(01): 089 doi: 10.1055/a-1957-8540
|
| 74 |
Liang Meng Loy, Hsien Min Low, Jin-Young Choi, Hyungjin Rhee, Chin Fong Wong, Cher Heng Tan. Variant Hepatocellular Carcinoma Subtypes According to the 2019 WHO Classification: An Imaging-Focused Review. American Journal of Roentgenology 2022; 219(2): 212 doi: 10.2214/AJR.21.26982
|
| 75 |
Laura Antonucci, Cristiana Porcu, Eleonora Timperi, Silvano Junior Santini, Gino Iannucci, Clara Balsano. Circulating Neutrophils of Nonalcoholic Steatohepatitis Patients Show an Activated Phenotype and Suppress T Lymphocytes Activity. Journal of Immunology Research 2020; 2020: 1 doi: 10.1155/2020/4570219
|
| 76 |
R. Leela-arporn, H. Ohta, N. Nagata, K. Sasaoka, M. Tamura, A. Dermlim, K. Nisa, K. Morishita, N. Sasaki, K. Nakamura, S. Takagi, K. Hosoya, M. Takiguchi. Epidemiology of massive hepatocellular carcinoma in dogs: A 4-year retrospective study. The Veterinary Journal 2019; 248: 74 doi: 10.1016/j.tvjl.2019.04.011
|
| 77 |
Naga S. Samji, Rajanshu Verma, Sanjaya K. Satapathy. Magnitude of Nonalcoholic Fatty Liver Disease: Western Perspective. Journal of Clinical and Experimental Hepatology 2019; 9(4): 497 doi: 10.1016/j.jceh.2019.05.001
|
| 78 |
Chunye Zhang, Shuai Liu, Ming Yang. The Role of Interferon Regulatory Factors in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. Gastroenterology Insights 2022; 13(2): 148 doi: 10.3390/gastroent13020016
|
| 79 |
Minhee Lee, Dakyung Kim, So Jung Park, Kyung Seok Kim, Geum Duck Park, Ok-Kyung Kim, Jeongmin Lee. Artichoke Extract Directly Suppresses Inflammation and Apoptosis in Hepatocytes During the Development of Non-Alcoholic Fatty Liver Disease. Journal of Medicinal Food 2021; 24(10): 1083 doi: 10.1089/jmf.2021.K.0069
|
| 80 |
Shinnichi Sakamoto, Atsuhiro Nagasaki, Madhu Shrestha, Tomoaki Shintani, Atsushi Watanabe, Hisako Furusho, Kazuaki Chayama, Takashi Takata, Mutsumi Miyauchi. Porphyromonas gingivalis-odontogenic infection is the potential risk for progression of nonalcoholic steatohepatitis-related neoplastic nodule formation. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-36553-y
|
| 81 |
Kimberly Liao, Anthony J. Pellicano, Kai Jiang, Natalia Prakash, Jingsong Li, Shraddha Bhutkar, Zhijian Hu, Quaisar Ali, Itzhak D. Goldberg, Prakash Narayan. Glycerol-3-phosphate Acyltransferase1 Is a Model-Agnostic Node in Nonalcoholic Fatty Liver Disease: Implications for Drug Development and Precision Medicine. ACS Omega 2020; 5(29): 18465 doi: 10.1021/acsomega.0c02350
|
| 82 |
Ik-Rak Jung, Rexford S. Ahima, Sangwon F. Kim. Time-Restricted Feeding Ameliorates Methionine–Choline Deficient Diet-Induced Steatohepatitis in Mice. International Journal of Molecular Sciences 2024; 25(3): 1390 doi: 10.3390/ijms25031390
|
| 83 |
Hui Emma Zhang, James M. Henderson, Mark D. Gorrell. Animal models for hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019; 1865(5): 993 doi: 10.1016/j.bbadis.2018.08.009
|
| 84 |
Pavla Staňková, Otto Kučera, Eva Peterová, Moustafa Elkalaf, David Rychtrmoc, Jan Melek, Miroslav Podhola, Veronika Zubáňová, Zuzana Červinková. Western Diet Decreases the Liver Mitochondrial Oxidative Flux of Succinate: Insight from a Murine NAFLD Model. International Journal of Molecular Sciences 2021; 22(13): 6908 doi: 10.3390/ijms22136908
|
| 85 |
. Febyan, Norman Delvano Weky. Obesity and Non-Alcoholic Fatty Liver Disease: Pathophysiology and Management Focused. European Journal of Medical and Health Sciences 2021; 3(1): 6 doi: 10.24018/ejmed.2021.3.1.645
|
| 86 |
Yize Zhang, Xue Liang, Qinghai Lian, Liwen Liu, Baoyu Zhang, Zihui Dong, Kunpeng Liu. Transcriptional analysis of the expression and prognostic value of lipid droplet-localized proteins in hepatocellular carcinoma. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10987-z
|
| 87 |
Anthony J. Pellicano, Kiera Spahn, Ping Zhou, Itzhak D. Goldberg, Prakash Narayan. Collagen Characterization in a Model of Nonalcoholic Steatohepatitis with Fibrosis; A Call for Development of Targeted Therapeutics. Molecules 2021; 26(11): 3316 doi: 10.3390/molecules26113316
|
| 88 |
Jiajie George Lu, Luan Nguyen, Sara Samadzadeh, Maryam Masouminia, Alejandro Mendoza, Owen Sweeney, Brittany Tillman, Nikoo Afifyan, Timothy Morgan, Barbara A. French, Samuel W. French. Expression of proteins upregulated in hepatocellular carcinoma in patients with alcoholic hepatitis (AH) compared to non-alcoholic steatohepatitis (NASH): An immunohistochemical analysis of candidate proteins. Experimental and Molecular Pathology 2018; 104(2): 125 doi: 10.1016/j.yexmp.2018.02.001
|
| 89 |
Pratima Dibba, Andrew A Li, George Cholankeril, Muhammad Ali Khan, Donghee Kim, Aijaz Ahmed. Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary. Nutrition and Metabolic Insights 2019; 12 doi: 10.1177/1178638819847480
|
| 90 |
Annika Rühle, Andrea Boskovic, Adrian T. Billeter, Anne-Catherine Schwarz, Beat P. Müller-Stich. Metabolische Chirurgie, mehr als nur Typ-2-Diabetes. Adipositas - Ursachen, Folgeerkrankungen, Therapie 2020; 14(04): 214 doi: 10.1055/a-1267-8215
|
| 91 |
Madalina-Gabriela Taru, Lidia Neamti, Vlad Taru, Lucia Maria Procopciuc, Bogdan Procopet, Monica Lupsor-Platon. How to Identify Advanced Fibrosis in Adult Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Using Ultrasound Elastography—A Review of the Literature and Proposed Multistep Approach. Diagnostics 2023; 13(4): 788 doi: 10.3390/diagnostics13040788
|
| 92 |
Man Hsin Hung, Xin Wei Wang. Hepatocellular Carcinoma. Molecular and Translational Medicine 2019; : 293 doi: 10.1007/978-3-030-21540-8_14
|
| 93 |
Daryl Ramai, Jameel Singh, Janice Lester, Shahab R. Khan, Saurabh Chandan, Nicola Tartaglia, Antonio Ambrosi, Gaetano Serviddio, Antonio Facciorusso. Systematic review with meta‐analysis: bariatric surgery reduces the incidence of hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 2021; 53(9): 977 doi: 10.1111/apt.16335
|
| 94 |
Daniel Hughes, Aron Hughes, Bilal Al-Sarireh. Hepatocellular carcinoma’s 100 most influential manuscripts: A bibliometric analysis. International Journal of Hepatobiliary and Pancreatic Diseases 2019; 9(2): 1 doi: 10.5348/100083Z04DH2019OA
|
| 95 |
Ken M. Chin, Mikel Prieto, Chin K. Cheong, Marcello Di Martino, Benedetto Ielpo, Brian K.P. Goh, Ye X. Koh. Outcomes after curative therapy for hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: a meta-analysis and review of current literature. HPB 2021; 23(8): 1164 doi: 10.1016/j.hpb.2021.01.009
|
| 96 |
Hui-Ting Chen, Hong-Li Huang, Yong-Qiang Li, Hao-Ming Xu, Yong-Jian Zhou. Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view. World Journal of Gastroenterology 2020; 26(16): 1901-1911 doi: 10.3748/wjg.v26.i16.1901
|
| 97 |
Amir Ajoolabady, Daolin Tang, Guido Kroemer, Jun Ren. Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy. British Journal of Cancer 2023; 128(2): 190 doi: 10.1038/s41416-022-01998-x
|
| 98 |
Matthew L. Holzner, Sander Florman, Myron E. Schwartz, Parissa Tabrizian. Outcomes of liver transplantation for nonalcoholic steatohepatitis-associated hepatocellular carcinoma. HPB 2022; 24(4): 470 doi: 10.1016/j.hpb.2021.08.943
|
| 99 |
Alicia Bort, Belén G. Sánchez, Pedro A. Mateos-Gómez, Inés Díaz-Laviada, Nieves Rodríguez-Henche. Capsaicin Targets Lipogenesis in HepG2 Cells Through AMPK Activation, AKT Inhibition and PPARs Regulation. International Journal of Molecular Sciences 2019; 20(7): 1660 doi: 10.3390/ijms20071660
|
| 100 |
Pradeep Kumar Rajan, Utibe-Abasi Udoh, Juan D. Sanabria, Moumita Banerjee, Gary Smith, Mathew Steven Schade, Jacqueline Sanabria, Komal Sodhi, Sandrine Pierre, Zijian Xie, Joseph I. Shapiro, Juan Sanabria. The Role of Histone Acetylation-/Methylation-Mediated Apoptotic Gene Regulation in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2020; 21(23): 8894 doi: 10.3390/ijms21238894
|
| 101 |
Manasi Kotulkar, Diego Paine-Cabrera, Udayan Apte. Role of Hepatocyte Nuclear Factor 4 Alpha in Liver Cancer. Seminars in Liver Disease 2024; 44(03): 383 doi: 10.1055/a-2349-7236
|
| 102 |
Baharan Fekry, Aleix Ribas-Latre, Corrine Baumgartner, Alaa M.T. Mohamed, Mikhail G. Kolonin, Frances M. Sladek, Mamoun Younes, Kristin L. Eckel-Mahan. HNF4α-Deficient Fatty Liver Provides a Permissive Environment for Sex-Independent Hepatocellular Carcinoma. Cancer Research 2019; 79(22): 5860 doi: 10.1158/0008-5472.CAN-19-1277
|
| 103 |
Monika Pazgan-Simon, Michał Kukla, Jolanta Zuwała-Jagiełło, Aleksandra Derra, Martyna Bator, Tomasz Menżyk, Andrzej Lekstan, Ewa Grzebyk, Krzysztof Simon, Matias A. Avila. Serum visfatin and vaspin levels in hepatocellular carcinoma (HCC). PLOS ONE 2020; 15(1): e0227459 doi: 10.1371/journal.pone.0227459
|
| 104 |
Ying Qi Goh, Guoxiang Cheam, Yulan Wang. Understanding Choline Bioavailability and Utilization: First Step Toward Personalizing Choline Nutrition. Journal of Agricultural and Food Chemistry 2021; 69(37): 10774 doi: 10.1021/acs.jafc.1c03077
|
| 105 |
Lung-Yi Mak, Vania Cruz-Ramón, Paulina Chinchilla-López, Harrys A. Torres, Noelle K. LoConte, John P. Rice, Lewis E. Foxhall, Erich M. Sturgis, Janette K. Merrill, Howard H. Bailey, Nahum Méndez-Sánchez, Man-Fung Yuen, Jessica P. Hwang. Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma. American Society of Clinical Oncology Educational Book 2018; (38): 262 doi: 10.1200/EDBK_200939
|
| 106 |
Evangelista Sagnelli, Margherita Macera, Antonio Russo, Nicola Coppola, Caterina Sagnelli. Epidemiological and etiological variations in hepatocellular carcinoma. Infection 2020; 48(1): 7 doi: 10.1007/s15010-019-01345-y
|
| 107 |
Luke V. Selby, Aslam Ejaz, Stacy A. Brethauer, Timothy M. Pawlik. Fatty liver disease and primary liver cancer: disease mechanisms, emerging therapies and the role of bariatric surgery. Expert Opinion on Investigational Drugs 2020; 29(2): 107 doi: 10.1080/13543784.2020.1721457
|
| 108 |
Takao Watanabe, Takeshi Imamura, Yoichi Hiasa. Roles of protein kinase R in cancer: Potential as a therapeutic target. Cancer Science 2018; 109(4): 919 doi: 10.1111/cas.13551
|
| 109 |
Kheng Song Leow, Christine Ying Kwok, Hsien Min Low, Rahul Lohan, Tze Chwan Lim, Su Chong Albert Low, Cher Heng Tan. Algorithm‐based approach to focal liver lesions in contrast‐enhanced ultrasound. Australasian Journal of Ultrasound in Medicine 2022; 25(3): 142 doi: 10.1002/ajum.12306
|
| 110 |
Heejun Son, Bo Kyung Koo, Sae Kyung Joo, Dong Hyeon Lee, Heejoon Jang, Jeong Hwan Park, Mee Soo Chang, Won Kim. PNPLA3 genotypes modify the adverse effect of the total energy intake on high-risk nonalcoholic steatohepatitis development. The American Journal of Clinical Nutrition 2023; 117(5): 910 doi: 10.1016/j.ajcnut.2023.02.024
|
| 111 |
Ryan Lamm, Peter J. Altshuler, Keyur Patel, Osama Shaheen, Angel Paulo Amante, Jesse Civan, Warren Maley, Adam Frank, Carlo Ramirez, Jaime Glorioso, Ashesh Shah, Hien Dang, Adam S. Bodzin. Reduced Rates of Post-Transplant Recurrent Hepatocellular Carcinoma in Non-Alcoholic Steatohepatitis: A Propensity Score Matched Analysis. Transplant International 2022; 35 doi: 10.3389/ti.2022.10175
|
| 112 |
Claire E. Thomas, Hung N. Luu, Renwei Wang, Jennifer Adams-Haduch, Aizhen Jin, Woon-Puay Koh, Jian-Min Yuan. Association between Dietary Tomato Intake and the Risk of Hepatocellular Carcinoma: The Singapore Chinese Health Study. Cancer Epidemiology, Biomarkers & Prevention 2020; 29(7): 1430 doi: 10.1158/1055-9965.EPI-20-0051
|
| 113 |
Eva Lieto, Gennaro Galizia, Francesca Cardella, Andrea Mabilia, Nicoletta Basile, Paolo Castellano, Michele Orditura, Annamaria Auricchio. Indocyanine Green Fluorescence Imaging-Guided Surgery in Primary and Metastatic Liver Tumors. Surgical Innovation 2018; 25(1): 62 doi: 10.1177/1553350617751451
|
| 114 |
Byeonggeun Kang, Byunghee Kang, Tae-Young Roh, Rho Hyun Seong, Won Kim. The Chromatin Accessibility Landscape of Nonalcoholic Fatty Liver Disease Progression. Molecules and Cells 2022; 45(5): 343 doi: 10.14348/molcells.2022.0001
|
| 115 |
Yuichiro Eguchi, Gabriel Wong, I‐Heng Lee, Omar Akhtar, Ricardo Lopes, Yoshio Sumida. Hepatocellular carcinoma and other complications of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in Japan: A structured review of published works. Hepatology Research 2021; 51(1): 19 doi: 10.1111/hepr.13583
|
| 116 |
Doina Georgescu, Daniel Lighezan, Ciprian Rosca, Daciana Nistor, Oana Ancusa, Ioana Suceava, Mihaela Iancu, Nilima Kundnani. NASH/NAFLD-Related Hepatocellular Carcinoma: An Added Burden. Life 2023; 14(1): 25 doi: 10.3390/life14010025
|
| 117 |
Zobair M. Younossi, Linda Henry. Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma. JHEP Reports 2021; 3(4): 100305 doi: 10.1016/j.jhepr.2021.100305
|
| 118 |
Douglas G. Mashek, Wenqi Cui, Linshan Shang, Charles P. Najt. The Liver. 2020; : 245 doi: 10.1002/9781119436812.ch21
|
| 119 |
Lorrane Viana, Rui Caetano Oliveira, Ricardo Martins, Henrique Alexandrino, Maria Augusta Cipriano, José Guilherme Tralhão. Prognostic Factors after Hepatectomy for Hepatocellular Carcinoma—The Importance of Pathological Immunophenotyping, the Steatohepatitic Subtype and the Impact of the Hepatic Pedicle Clamping. Gastrointestinal Disorders 2024; 6(2): 402 doi: 10.3390/gidisord6020027
|
| 120 |
Danny Orabi, Nathan A. Berger, J. Mark Brown. Abnormal Metabolism in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Mechanistic Insights to Chemoprevention. Cancers 2021; 13(14): 3473 doi: 10.3390/cancers13143473
|
| 121 |
Xueqing Huang, Dengwei You, Tianzhi An, Xuya Zhao, Tianpeng Jiang, Zhi Huang. Glycyrrhizic acid attenuates the malignant biological properties of nonalcoholic fatty liver disease‐related hepatocellular carcinoma. Environmental Toxicology 2024; 39(10): 4677 doi: 10.1002/tox.24295
|
| 122 |
Meenakshi Vachher, Savita Bansal, Bhupender Kumar, Sandeep Yadav, Taruna Arora, Nalini Moza Wali, Archana Burman. Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma. Journal of Cellular Biochemistry 2022; 123(10): 1553 doi: 10.1002/jcb.30252
|
| 123 |
Xu Li, Xiaocong Wang, Pujun Gao. Diabetes Mellitus and Risk of Hepatocellular Carcinoma. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/5202684
|
| 124 |
Hailey H. Choi, Shuchi K. Rodgers, Aman Khurana, Leslie W. Nelson, Aya Kamaya. Role of Ultrasound for Chronic Liver Disease and Hepatocellular Carcinoma Surveillance. Magnetic Resonance Imaging Clinics of North America 2021; 29(3): 279 doi: 10.1016/j.mric.2021.05.005
|
| 125 |
Yue Jia, Ping Ji, Barbara French, Brittany Tillman, Samuel W. French. The different expression of tumor suppressors, RASSF1A, RUNX3, and GSTP1, in patients with alcoholic steatohepatitis (ASH) vs non-alcoholic steatohepatitis (NASH). Experimental and Molecular Pathology 2019; 108: 156 doi: 10.1016/j.yexmp.2019.04.002
|
| 126 |
Maria Corina Plaz Torres, Ariel Jaffe, Rachel Perry, Elisa Marabotto, Mario Strazzabosco, Edoardo G. Giannini. Diabetes medications and risk of HCC. Hepatology 2022; 76(6): 1880 doi: 10.1002/hep.32439
|
| 127 |
Eman D. Mohammed, Ashraf B. Abdel-Naim, Jin Kangpeng, Runqiu Jiang, Jifu Wei, Beicheng Sun. The mother relationship between insulin resistance and non-alcoholic steatohepatitis: Glucosinolates hydrolysis products as a promising insulin resistance-modulator and fatty liver-preventer. Life Sciences 2021; 264: 118615 doi: 10.1016/j.lfs.2020.118615
|
| 128 |
Nikolaus Berndt, Johannes Eckstein, Niklas Heucke, Robert Gajowski, Martin Stockmann, David Meierhofer, Hermann-Georg Holzhütter. Characterization of Lipid and Lipid Droplet Metabolism in Human HCC. Cells 2019; 8(5): 512 doi: 10.3390/cells8050512
|
| 129 |
José M Mato, Cristina Alonso, Mazen Noureddin, Shelly C Lu. Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease. World Journal of Gastroenterology 2019; 25(24): 3009-3020 doi: 10.3748/wjg.v25.i24.3009
|
| 130 |
Hyunmi Kim, Da Som Lee, Tae Hyeon An, Hyun-Ju Park, Won Kon Kim, Kwang-Hee Bae, Kyoung-Jin Oh. Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC. International Journal of Molecular Sciences 2021; 22(9): 4495 doi: 10.3390/ijms22094495
|
| 131 |
Frederico Costa, Bertram Wiedenmann, Christoph Roderburg, Raphael Mohr, Ghassan K. Abou‐Alfa. Systemic treatment in patients with Child–Pugh B liver dysfunction and advanced hepatocellular carcinoma. Cancer Medicine 2023; 12(13): 13978 doi: 10.1002/cam4.6033
|
| 132 |
Corina Pop, Sorina Diaconu. Essentials of Non-Alcoholic Fatty Liver Disease. 2023; : 45 doi: 10.1007/978-3-031-33548-8_4
|